AJG vs RGEN · P/E 33, rev $8.76B vs P/E 143, rev $204.1M
Arthur J Gallagher & Co (AJG) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the AJG and RGEN stock pages for the full models.
Not investment advice.